Is selective prenatal iron prophylaxis better than routine prophylaxis: final results of a trial (PROFEG) in Maputo, Mozambique

Elina Hemminki, Bright I Nwaru, Graca Salomé, Saara Parkkali, Fatima Abacassamo, Orvalho Augusto, Julie Cliff, Elena Regushevskaya, Martinho Dgedge, Cesar Sousa, Baltazar Chilundo, Elina Hemminki, Bright I Nwaru, Graca Salomé, Saara Parkkali, Fatima Abacassamo, Orvalho Augusto, Julie Cliff, Elena Regushevskaya, Martinho Dgedge, Cesar Sousa, Baltazar Chilundo

Abstract

Objective: To compare routine versus selective (ie, screening and treatment for anaemia) prenatal iron prophylaxis in a malaria-endemic and HIV-prevalent setting, an extended analysis including previously missing data.

Design: A pragmatic randomised controlled clinical trial.

Setting: 2 health centres in Maputo, Mozambique.

Participants: Pregnant women (≥18 years old; non-high-risk pregnancy) were randomly allocated to routine iron (n=2184) and selective iron (n=2142) groups.

Interventions: In the routine group, women received 60 mg ferrous sulfate plus 400 μg folic acid daily. In the selective group, women received 1 mg of folic acid daily and haemoglobin (Hb) screening at each visit; with low Hb (cut-off 9 g/dL) treatment (120 mg+800 μg of folic acid daily) for a month.

Primary outcomes: preterm birth, low birth weight; secondary outcomes: self-reported malaria, labour complications, caesarean section, perinatal death, woman's death. Nurses collected pregnancy data. Birth data were abstracted from hospital records for 52% of women and traced using various methods and linked with probabilistic matching for 24%. Women's deaths were collected from death registers.

Results: Birth data were available for 3301 (76%) of the women. Outcomes were similar in the two groups: preterm births (27.1% in the selective vs 25.3% in the routine group), low birthweight infants (11.0% vs 11.7%), perinatal deaths (2.4% vs 2.4%) and caesarean sections (4.0% vs 4.5%). Women's deaths during pregnancy or <42 days postpartum were more common in the selective group (0.8% among the two best matched women) than in the routine group (0.4%). Extra deaths could not be explained by the cause of death, Hb level or HIV status at recruitment.

Conclusions: Birth outcomes were similar in the two iron groups. There might have been more women's deaths in the selective iron group, but it is unclear whether this was due to the intervention, other factors or chance finding.

Trial registration number: NCT00488579.

Keywords: birth; iron supplementation; malaria; pragmatic trial; pregnancy.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Figures

Figure 1
Figure 1
PROFEG trial flow diagram.1 ARO, high-risk pregnancy; 2 GA, gestational age in weeks; 3 After recruitment, % were calculated from recruited, n=4326.

References

    1. Stoltzfus R, Dreyfuss M. Guidelines for the use of iron supplements to prevent and treat iron deficiency anaemia. ILSI Press, 1998.
    1. World Health Organization. Micronutrient deficiencies: iron deficiency anaemia.
    1. World Health Organization. The prevalence of anaemia in women: a tabulation of available information (WHO/MCH/MSM/92). 2nd edn WHO, Maternal Health and Safe Motherhood Programme, Division of Family Health, 1992.
    1. Lao TT, Tam KF, Chan LY. Third trimester iron status and pregnancy outcome in non-anaemic women: pregnancy unfavourably affected by maternal iron excess. Hum Reprod 2000;15:1843–8. 10.1093/humrep/15.8.1843
    1. Yip R. Significance of an abnormally low or high hemoglobin concentration during pregnancy: special consideration of iron nutrition. Am J Clin Nutr 2000;72(Suppl):272S–9S.
    1. Peña-Rosas JP, Viteri FE. Effects and safety of preventive oral iron or iron+folic acid supplementation for women during pregnancy. Cochrane Database Syst Rev 2009, (4):CD004736.
    1. Villar J. Merialdi M, Gulmezoglu AM et al. . Nutritional interventions during pregnancy for the prevention or treatment of maternal mortality and preterm delivery: an overview of randomized controlled trials. J Nutr 2003;133:1606–25.
    1. Haider BA, Olofin I, Wang M et al. . Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ 2013;346:f3443 10.1136/bmj.f3443
    1. Etheredge AJ, Premji Z, Gunaratna NS et al. . Iron supplementation in iron-replete nonanemic pregnant women in Tanzania: a randomized clinical trial. JAMA Pediatr 2015;169:947–55. 10.1001/jamapediatrics.2015.1480
    1. Mwangi MN, Roth JM, Smit MR et al. . Effect of daily antenatal iron supplementation plasmodium infection in Kenyan women: a randomized clinical trial. JAMA 2015; 314: 1009–20. 10.1001/jama.2015.9496
    1. Oppenheimer SJ. Iron and its relation to immunity and infectious disease. J Nutr 2001;131:616S–35S.
    1. Prentice AM. Iron metabolism, malaria, and other infections: what is all the fuss about? J Nutr 2008;138:2537–41. 10.3945/jn.108.098806
    1. Gera T, Sachdev HP. Effect of iron supplementation on incidence of infectious illness in children: systematic review. BMJ 2002;325:1142.
    1. Lawn JE, Cousens S, Zupan J, Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: when? Where? Why? Lancet 2005;365:891–900. 10.1016/S0140-6736(05)71048-5
    1. Idemyor V. Human immunodeficiency virus (HIV) and malaria interaction in sub-Saharan Africa: the collision of two titans. HIV Clin Trials 2007;8:246–53. 10.1310/hct0804-246
    1. Sazawal S, Black RE, Ramsan M et al. . Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomized, placebo-controlled trial. Lancet 2006;367:133–43. 10.1016/S0140-6736(06)67962-2
    1. Nwaru BI, Parkkali S, Abacassamo F et al. . A pragmatic randomised controlled trial on routine iron prophylaxis during pregnancy in Maputo, Mozambique (PROFEG): rationale, design, and success. Matern Child Nutr 2015;11:146–63. 10.1111/mcn.12006
    1. Parkkali S, Abacassamo F, Nwaru BI et al. . Comparison of routine prenatal iron prophylaxis and screening and treatment for anaemia: pregnancy results and preliminary birth results from a pragmatic randomized controlled trial (PROFEG) Maputo Mozambique. BMJ Open 2013;3:e001948 10.1136/bmjopen-2012-001948
    1. Dgedge M. Implementation of an insecticide Bednet programme for malaria prevention through the primary health care system in Mozambique [Doctoral thesis]. London School of Hygiene and Tropical Medicine, 2000.
    1. Nwaru BI, Salomé G, Abacassamo F et al. . Adherence in a pragmatic randomized controlled trial on prophylactic iron supplementation during pregnancy in Maputo, Mozambique. Public Health Nutr 2015;18:1127–34. 10.1017/S1368980014001359
    1. Little RJA, Rubin DB. Statistical analysis with missing data. 2nd edn Hoboken, NJ: Wiley-InterScience, 2002.
    1. Fleming AF, Ghatoura GB, Harrison KA et al. . The prevention of anaemia in pregnancy in primigravidae in the Guinea savanna of Nigeria. Ann Trop Med Parasitol 1986;80:211–33.
    1. Ndyomugyenyi R, Magnussen P. Chloroquine prophylaxis, iron/folic-acid supplementation or case management of malaria attacks in primigravidae in western Uganda: effects on congenital malaria and infant haemoglobin concentrations. Ann Trop Med Parasitol 2000;94:759–70. 10.1080/00034980020015189
    1. Juncker T, Ameer S, Mmaum A et al. . A trial of iron and folate supplementation during pregnancy in Bangladesh. Atlanta, USA: Abstract presented at the American Public Health Association, 2001.
    1. Menendez C, Todd J, Alonso PL et al. . The effects of iron supplementation during pregnancy, given by traditional birth attendants, on the prevalence of anaemia and malaria. Trans R Soc Trop Med Hyg 1994;88:590–3. 10.1016/0035-9203(94)90176-7
    1. Preziosi P, Prual A, Galan P et al. . Effect of iron supplementation on the iron status of pregnant women: consequences for newborns. Am J Clin Nutr 1997;66:1178–82.
    1. Choi JH, Yates Z, Veysey M et al. . Contemporary issues surrounding folic acid fortification initiatives. Prev Nutr Food Sci 2014;19:247–60. 10.3746/pnf.2014.19.4.247
    1. Stone JE, Simmons WK, Jutsum PJ et al. . An evaluation of methods of screening for anaemia. Bull World Health Organ 1984;62:115–20.
    1. Van Lerberghe W, Keegels G, Cornelis G et al. . Haemoglobin measurement: the reliability of some simple techniques for use in a primary health care setting. Bull World Health Organ 1983;61:957–65.
    1. Srivastava T, Negandhi H, Neogi SB et al. . Methods for Hemoglobin Estimation: a review of “What Works”. J Hematol Transfus 2014;2:1028.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다